{
  "url": "https://www.law.cornell.edu/regulations/new-york/9-NYCRR-132.6",
  "title": "N.Y. Comp. Codes R. & Regs. Tit. 9 ยง 132.6 - Research Involving Human Subjects",
  "content": "N.Y. Comp. Codes R. & Regs. Tit. 9 ยง 132.6 - Research Involving Human Subjects\n\nState Regulations\n(a) Prior to receiving a research license for a research project that includes\nhuman subjects, the following shall be required: (1)\none or more licensed practitioners in\ngood standing to monitor participants shall be included, if required by the IRB\nof record; (2)\nfor any research\nproject involving the consumption of investigational products by human\nsubjects: (i) all products shall be tested in\naccordance with Part 130 of this Title; (ii)\nresearch participants shall be subject\nto all applicable laws and regulations; and\n(3)\nfor any multi-site research projects\ninvolving the consumption of investigational products by human subjects, all\nresearch sites shall be located in New York State. (b) Prior to receiving a research license for\na research project that includes human subjects, the applicant shall submit\nevidence of approval or exemption of the project by the identified IRB. Evidence of IRB approval or exemption may be submitted separately from the\ninformation required in this part but shall be submitted to receive a final\nresearch license. (c) Advertisements used to recruit human subjects must be reviewed and approved by\nthe IRB of record. (d) An applicant\nor research licensee shall be prohibited from conducting any research involving\nhuman subjects unless: (1)\nall aspects of its\nproposed research project have been reviewed and approved by an IRB that is\nregistered and in good standing with the Office for Human Research and\n\nProtections, U.S. Department of Health and Human Services; (2)\nthe applicant provides copies to the\n\nOffice of the IRB's determination that: (i) the research project has been conditionally approved and is pending final\napproval; (ii)\nthe research project\nhas been approved; or\n(iii)\nthe\nresearch project has been exempted from IRB review. (e) A research licensee shall at\nall times comply with requirements for protection of human subjects, including\nadditional safeguards necessary for vulnerable populations, such as children, prisoners, pregnant women, mentally disabled persons, or economically or\neducationally disadvantaged persons, Title 45 of the Code of Federal\n\nRegulations Part 46, and all other relevant federal and/or state laws and\nregulations regarding research on human subjects, as well as all prevailing\nethical standards and requirements for research involving human\nsubjects. (f) A research licensee\nshall abide by the following conditions when utilizing an informed consent form\nin research involving human subjects: (1)\nA\nresearch licensee shall ensure informed consent from any individual\nparticipating in such research is obtained prior to the individual's\nparticipation in the research project. For studies involving minors, the\nresearch licensee shall also ensure assent from minors is obtained, as\ndetermined by the IRB of record. (2)\nA research licensee shall comply with\nrequirements for informed consent, specifically the safeguards for children in\nclinical investigations, under Title 21 of the Code of Federal Regulations Part\n50, as part of approval and ongoing oversight and review by an IRB, including, but not limited to: (i) sufficient opportunity\nto consider whether or not to participate; (ii)\ninformation given to the participant is\nin a language and reading level understandable to the participant or their\nrepresentative; and\n(iii)\nthe ICF\nshall not include any language that waives or appears to waive the\nparticipant's legal rights, nor appears to release the PI or the research\nlicensee from liability for negligence. (3)\nA copy of the signed ICF and\ndocumentation showing that the process of obtaining informed consent complied\nwith the research licensee's IRB standards shall be available to the Office\nupon request. (g) A\nresearch licensee may serve as a designated caregiver, or a designated\ncaregiver facility, provided that: (i) the\nresearch licensee registers as a designated caregiver or designated caregiver\nfacility, as applicable, in accordance with Part 113 of this Title; and\n(ii)\nthe investigational\nproducts are purchased exclusively from a registered organization. (h) PHI may be used or reported in\nan aggregated, nonidentifiable form. (i) A research licensee shall not disclose\nthe PHI of human subjects participating in the research project. Participant\nrecords shall be confidential and shall not be subject to disclosure under the\n\nFreedom of Information Law. If necessary, and upon written request to the\n\nOffice, reasonable access to participant records obtained under this part may\nbe provided to: (1)\nthe Office and local law\nenforcement agencies for purposes of investigating and enforcing what is set\nforth in any applicable regulation; (2)\nlicensed practitioners, advanced practice\nregistered nurses, pharmacists or other dispensaries for the purpose of\nproviding patient care and drug therapy management; (3)\nthe human subject participating in the\nresearch project, but only with respect to information related to the human\nsubject, themselves; (4)\nthird\nparty payors who pay claims for a qualifying patient's medical cannabis or who\nhave a formal agreement or contract to audit any records or information in\nconnection with such claims; (5)\nany person, the state or federal government, or any agency thereof pursuant to\nan order of a court of competent jurisdiction or pursuant to a search warrant; and\n(6)\nany person upon the express\nwritten consent of the human subject and only with respect to information\nrelated to such human subject. Such written consent shall clearly identify the\nspecific human subject and purpose for which consent is being granted, but in\nno event shall such information be disclosed for data capture into an EDC\nsystem. (j) No\nelectronic equipment utilized by a dispensary shall collect a research\nparticipant's PHI for use outside of the research project unless: (1)\nthe patient has consented to the release\nof PHI by informed consent; or\n(2)\nthe Office has requested PHI be disclosed for purposes of an inspection or\ninvestigation. (k) No\nelectronic equipment utilized by an approved research project shall collect PHI\nspecific to human subjects for use outside of the research project, except that\nsuch data shall be disclosed to the Office or law enforcement for purposes of\nan inspection or investigation. (l) A research licensee, key personnel, or research participant who is acting\nwithin the scope of his or her involvement in an approved research project\nshall not be subject to arrest or prosecution, penalized in any manner, including, but not limited to, being subject to any civil penalty or denied any\nright or privilege, including, but not limited to, being subject to any\ndisciplinary action by a professional licensing board, for the use of\ninvestigational products. (m) The\nprovisions of subdivision (l) of this section shall not apply to: (1)\nany use of investigational products that\nendangers the health or well-being of a person other than the research subject\nor a research project employee; or\n(2)\nthe use or consumption of investigational\nproducts: (i) in a motor bus or a school bus\nor in any other moving vehicle; (ii)\non any school grounds unless it is the\nsite of a research project and such use is pursuant to the terms of the\napproved research project; or\n(iii)\nin any public place, unless required by an approved research project. Notes\nN.Y. Comp. Codes\nR. & Regs. Tit. 9\nยง\n132.6\n\nAdopted\n\nNew\n\nYork State Register August 9, 2023/Volume XLV, Issue 32, eff. 8/9/2023\n\nState regulations are updated quarterly; we currently have two versions available. Below is a\ncomparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare. No prior version found.",
  "url_type": "regulation",
  "source_index": 1410
}